Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ALVO stock hub

Alvotech has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALVOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALVO

In the news

Latest news · ALVO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E90.7

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-14.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALVO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001898416
Company name	Alvotech
Country	Luxembourg
Country code	US
Cusip	L01800108
Employees	1,279
Employees Change	267%
Employees Change Percent	26.38
Enterprise value	$2.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	LU2458332611
Last refreshed	2026-05-10
Market cap	$1B
Market cap category	Small-Cap
Price	$3.26
Price currency	USD
Rev Per Employee	439,439.41x
Sector	Healthcare
Sic	2836
Symbol	ALVO
Website	https://www.alvotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.91%
EV Sales Forward	3.45x
EV/EBIT	29.47x
EV/EBITDA	22.97x
EV/Sales	4.29x
FCF yield	-16.82%
Forward P/E	90.75x
P/S ratio	1.82x
PS Forward	1.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.57%
EBITDA Margin	18.7%
Gross margin	61.53%
Gross Profit	$345.8M
Gross Profit Growth	-3.15%
Gross Profit Growth Q	-11.14%
Gross Profit Growth3 Y	460.41%
Net Income	$-80.7M
Net Income Growth Q	-99.06%
Net Income Growth Years	2%
Pretax Margin	7.81%
Profit Margin	-14.36%
Profit Per Employee	$-63,120
Profitable Years	1
ROA	3.84
Roa5y	-12.99
ROCE	7.05
ROIC	-14.32
Roic5y	-114.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-58.97%
Cagr3y	-30.63%
Cagr5y	-20.05%
EPS Growth Q	-99.06
EPS Growth Years	3
Revenue Growth	-4.4x
Revenue Growth Q	-20.23x
Revenue Growth Quarters	2x
Revenue Growth Years	4x
Revenue Growth3 Y	77.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$1.4B
Cash	$63.8M
Current Assets	$456M
Current Liabilities	$259.8M
Debt	$1.5B
Debt EBITDA	$13.87
Equity	$-282.3M
Interest Coverage	0.54
Liabilities	$1.7B
Long Term Assets	$965.2M
Long Term Liabilities	$1.4B
Net Cash	$-1.4B
Net Cash By Market Cap	$-137
Net Debt EBITDA	$13.26
Tangible Book Value	$-414.4M
Tangible Book Value Per Share	$-1.33
WACC	-9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.76
Inventory Turnover	1.17
Net Working Capital	$188M
Quick ratio	0.66
Working Capital	$196.2M
Working Capital Turnover	$2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-58.94%
200-day SMA	5.86
3Y total return	-66.63%
50-day SMA	3.56
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.33%
All Time High	18
All Time High Change	-81.89%
All Time High Date	2024-02-26
All Time Low	3.03
All Time Low Change	7.59%
All Time Low Date	2026-03-24
ATR	0.2
Beta	0.21
Beta1y	1.52
Beta2y	1.03
Ch YTD	-36.45
High	3.32
High52	11.85
High52 Date	2025-06-04
High52ch	-72.49%
Low	3.17
Low52	3.03
Low52 Date	2026-03-24
Low52ch	7.59%
Ma50ch	-8.53%
Premarket Change Percent	0.41
Premarket Price	$3.21
Premarket Volume	3,359
Price vs 200-day SMA	-44.38%
RSI	42.06
RSI Monthly	31.79
RSI Weekly	30.57
Sharpe ratio	-1.01x
Sortino ratio	-1.25
Total Return	-9.55%
Tr YTD	-36.45
Tr1m	-3.83%
Tr1w	-5.78%
Tr3m	-36.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$6
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.03
Earnings EPS Estimate Growth	-91.43
Earnings Revenue Estimate	139,910,200x
Earnings Revenue Estimate Growth	5.35x
Operating Income	$81.9M
Operating Income Growth	-36.74
Operating Income Growth Q	-8.58
Operating margin	14.57
Price target	$8
Price Target Change	$145
Price Target Change Top	$84.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	114,453,504%
Float Percent	36.56%
Net Borrowing	204,821,000
Shares Insiders	0.45%
Shares Institutions	4.9%
Shares Out	313,018,977
Shares Qo Q	8.4%
Shares Yo Y	9.55%
Short Float	2.36%
Short Ratio	4.98
Short Shares	0.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-180M
Average Volume	375,554.15x
Bv Per Share	-0.9
CAPEX	$-48.4M
Ch1m	-3.83
Ch1w	-5.78
Ch1y	-58.94
Ch3m	-36.33
Ch3y	-66.63
Ch5y	-67.33
Ch6m	-42.91
Change	1.87%
Change From Open	1.56
Close	3.2
Days Gap	0.31
Depreciation Amortization	23,202,000
Dollar Volume	1,532,112
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$81.9M
EBITDA	$105.1M
EPS	$-0.26
F Score	3
FCF	$-171.6M
FCF EV Yield	-7.11x
FCF Per Share	$-0.55
Financing CF	275,704,000
Fiscal Year End	December
Founded	2,013
Goodwill	12,514,000
Income Tax	$124.6M
Investing CF	-130,015,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	5.01
Ma150ch	-34.87%
Ma20	3.48
Ma20ch	-6.19%
Net CF	25,288,000
Next Earnings Date	2026-08-12
Open	3.21
Optionable	No
Position In Range	60
Post Close	3.26
Postmarket Change Percent	-1.23
Postmarket Price	$3.22
Ppne	495,227,000
Pre Close	3.2
Price Date	2026-05-08
Price EBITDA	$9.71
Relative Volume	1.25x
Revenue	562,043,000x
SBC By Revenue	1.5x
Share Based Comp	8,414,000
Tax By Revenue	22.18x
Tax Rate	283.84%
Tr6m	-42.91%
Volume	469,973

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALVO pay a dividend?

Capital-return profile for this ticker.

Performance

ALVO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALVO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.9%

Float: +36.6% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALVO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-44.4%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

-1.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALVO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALVO stock rating?

Alvotech is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALVO analysis?

The full report lives at /stocks/ALVO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALVO?

The latest report frames ALVO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALVO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.